Not investment advice. Educational platform. See Disclaimer.
NASDAQ: VTRS
Viatris Inc.
Healthcare | Drug Manufacturers - Specialty & Generic
$16.97+0.03 (+0.18%)as of 2026-09-04 18:39 UTC
Market Cap$19.8B
Volume1.76M
EPS (TTM)$-3.00
Viatris Inc. (NASDAQ: VTRS) is a $19.8B drug manufacturers - specialty & generic company trading at $16.97 (+0.2% today). Figures from SEC EDGAR and market feeds; updated 2026-09-04 18:39 UTC.
52-Week Range
Low $14.56High $18.39
What Viatris Inc. does
Viatris is a global healthcare company that supplies medicines to approximately one billion patients annually across more than 165 countries and territories. The company operates a diverse portfolio consisting of generic drugs, established brand-name medicines, and innovative pharmaceutical products, supported by more than 1,400 approved molecules and 27 manufacturing and distribution sites worldwide.
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
2026-05-04Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
Viatris is a global healthcare company that supplies medicines to approximately one billion patients annually across more than 165 countries and territories.
What is VTRS's valuation?
VTRS trades at $16.97, as of 2026-09-04.
When did VTRS last file with the SEC?
Viatris Inc.'s most recent SEC filing on record is a 8-K filed 2026-07-01. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-09-04 18:39 UTC. This page is also available as JSON at /api/data?ticker=VTRS and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for VTRS and 5,000+ tickers.
